Parabilis' $670M IPO sets new biotech record, will fund cancer drug

June 9, 2026 09:21 PM EDT IPOs Para­bil­is' $670M IPO sets new biotech record, will fund can­cer drug Kyle LaHucik Biotech Correspondent De­spite all the noise around up­com­ing mas­sive IPOs for AI gi­ants, a drug de­vel­op­er was able to at­tract enough in­vestor in­ter­est to achieve the biggest … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER